CERA

Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

Events

Join pioneering ocular gene therapy researcher Professor Jean Bennett and CERA scientists for an enlightening discussion about the sight-saving potential of gene therapy at the 15th annual Gerard Crock Lecture.  

Hope in Sight Giving Day

Thanks to your incredible support, we raised $187,607 to advance our research to find new treatments for eye diseases that cause vision loss and blindness. It’s research that could have a life-changing impact for people like Maggie, who lives with low vision from Usher Syndrome.

Consumer involvement

Our new Consumer Program is working alongside people with lived experience to ensure their insights are at the heart of advancing eye research. Learn about the program and meet our Consumer Advisory Group.

Celebrating Cerulea Clinical Trials

Cerulea Clinical Trials, CERA’s new not-for-profit clinical trials centre, is up and running.
Learn how Cerulea will transform the delivery of ophthalmic clinical trials, increase community access to sight-saving therapies and deliver excellence for clinicians, trial participants and sponsors.

Read more

Take part in research

Help shape the future of vision research by taking part in a clinical study.
Find out how you can take part in studies at CERA and Cerulea Clinical Trials for eye conditions including age-related macular degeneration, corneal conditions, diabetic retinopathy, glaucoma and inherited retinal disease.

Learn more

Latest News


Research

06 November 2024

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision loss in ‘wet’ age-related macular degeneration and diabetic eye disease.

Stories

01 November 2024

Melbourne woman Shelley Kline has raised more than $500,000 for research into eye disease as a tribute to the iconic Professor Frank Billson. CERA researchers are among those benefitting from the generous scholarship.

News

04 October 2024

CERA’s Consumer Advisory Group will bring the voices of consumers into the heart of vision research.

Research

19 September 2024

Researchers at CERA are working to expand gene therapy technology to increase the number of treatments for blindness-causing genetic disorders.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals